Doctor profile · Federal record

Dr. Melissa Renzi, FNP-BC

Nurse Practitioner · Nurse Practitioner · Flourtown, PA

  • NPI 1912498767
  • Accepts Medicare
  • 9 yrs in practice
  • Licensed in 2 states
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1107 Bethlehem Pike Ste 103
Flourtown, PA 190311919
(152) 547-0702
fax (215) 254-7079
Additional location
301 N Route 73
West Berlin, NJ 080912508
(844) 542-2273
Mailing address
1107 Bethlehem Pike Ste 103&210
Flourtown, PA 190311919

Credentials & registration

NPPES · NUCC
NPI registered
May 2018 — 8 yrs on file
Profile last updated
October 29, 2024
Year of graduation
2017 — 9 yrs since
Specialty taxonomy
363L00000X — NUCC code
State licenses (2)
Pennsylvania #SP018896 · New Jersey #26NJ00829200

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912498767. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
678
Distinct HCPCS
10
Medicare allowed
$36,928
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 211 40 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 153 119 $81
11102 Biopsy of related skin growth, first growth 85 80 $89
17000 Destruction of precancer skin growth, 1 growth 83 65 $47
99203 New patient office or other outpatient visit, 30-44 minutes 42 42 $101
99212 Established patient office or other outpatient visit, 10-19 minutes 29 29 $51
17110 Destruction of skin growth, 1-14 growths 27 25 $104
11103 Biopsy of related skin growth, each additional growth 24 17 $46
99202 New patient office or other outpatient visit, 15-29 minutes 13 13 $65
99214 Established patient office or other outpatient visit, 30-39 minutes 11 11 $115

In context: peer comparison

Among 2 peers in Flourtown Nurse Practitioner, average services per provider: 54. This provider delivers 13× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,322
Transactions
119
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 33 $467.89
Genzyme Corporation 6 $271.10
Leo Pharma INC. 16 $253.48
Lilly USA, LLC 13 $247.60
Sun Pharmaceutical Industries INC. 10 $215.79
Novartis Pharmaceuticals Corporation 9 $208.54
Janssen Biotech, INC. 12 $190.21
Regeneron Healthcare Solutions, INC. 6 $109.53
Amgen INC. 3 $84.27
E.R. Squibb & Sons, L.L.C. 3 $62.75
Galderma Laboratories, L.P. 3 $49.44
Verrica Pharmaceuticals INC. 2 $42.98
Paratek Pharmaceuticals, INC. 1 $23.81
Dermavant Sciences, INC. 1 $22.25
Ucb, INC. 1 $21.67

By nature of payment

Food and Beverage
$2,322

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
249
Patients
152
Total drug cost
$5,881
Drug Type Claims Patients Total cost
Ketoconazole Generic 67 36 $1,289
Triamcinolone Acetonide Generic 57 42 $836
Clobetasol Propionate Generic 44 34 $1,714
Hydrocortisone Generic 37 27 $207
Clindamycin Phosphate Generic 18 0 $992
Desonide Generic 15 13 $519
Ammonium Lactate Generic 11 0 $324

Frequently asked questions

Auto-generated from federal data
What is Dr. Melissa Renzi's medical specialty?
Dr. Melissa Renzi practices Nurse Practitioner in Flourtown, PA.
Where does Dr. Melissa Renzi practice?
Dr. Melissa Renzi practices at 1107 Bethlehem Pike Ste 103, Flourtown, PA 190311919. Office phone: 1525470702.
What is Dr. Melissa Renzi's NPI?
Dr. Melissa Renzi's National Provider Identifier (NPI) is 1912498767, issued by NPPES.
Does Dr. Melissa Renzi accept Medicare assignment?
Yes. Dr. Melissa Renzi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melissa Renzi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.